Healthcare Global Enterprises Limited (HCG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Healthcare Global Enterprises Limited (HCG) has a cash flow conversion efficiency ratio of 0.193x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.92 Billion ≈ $20.79 Million USD) by net assets (Rs9.94 Billion ≈ $107.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Healthcare Global Enterprises Limited (HCG) balance sheet quality index to measure how much of total assets are equity-financed.
Healthcare Global Enterprises Limited - Cash Flow Conversion Efficiency Trend (2011–2026)
This chart illustrates how Healthcare Global Enterprises Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Healthcare Global Enterprises Limited's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Healthcare Global Enterprises Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Healthcare Global Enterprises Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Wuxi Dk Electronic Materials Co Ltd
SHE:300842
|
0.288x |
|
BKI Investment Company Ltd
AU:BKI
|
0.025x |
|
Manchester United Ltd
F:MUF
|
-0.060x |
|
Petkim Petrokimya Holding AS
IS:PETKM
|
0.034x |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
-0.073x |
|
Zhejiang Fulai New Material Co.Ltd.
SHG:605488
|
0.025x |
|
Instalco Intressenter AB
ST:INSTAL
|
0.133x |
|
CONMED Corporation
NYSE:CNMD
|
0.013x |
Annual Cash Flow Conversion Efficiency for Healthcare Global Enterprises Limited (2011–2026)
The table below shows the annual cash flow conversion efficiency of Healthcare Global Enterprises Limited from 2011 to 2026. For the full company profile with market capitalisation and key ratios, see market cap of Healthcare Global Enterprises Limited.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs14.10 Billion ≈ $152.51 Million |
Rs3.47 Billion ≈ $37.54 Million |
0.246x | -23.15% |
| 2025-03-31 | Rs9.90 Billion ≈ $107.07 Million |
Rs3.17 Billion ≈ $34.29 Million |
0.320x | -2.63% |
| 2024-03-31 | Rs8.65 Billion ≈ $93.56 Million |
Rs2.85 Billion ≈ $30.78 Million |
0.329x | +13.67% |
| 2023-03-31 | Rs8.69 Billion ≈ $94.02 Million |
Rs2.52 Billion ≈ $27.21 Million |
0.289x | +16.17% |
| 2022-03-31 | Rs8.84 Billion ≈ $95.57 Million |
Rs2.20 Billion ≈ $23.81 Million |
0.249x | +47.57% |
| 2021-03-31 | Rs7.14 Billion ≈ $77.22 Million |
Rs1.21 Billion ≈ $13.03 Million |
0.169x | -45.55% |
| 2020-03-31 | Rs4.20 Billion ≈ $45.40 Million |
Rs1.30 Billion ≈ $14.07 Million |
0.310x | +64.35% |
| 2019-03-31 | Rs5.22 Billion ≈ $56.47 Million |
Rs985.04 Million ≈ $10.65 Million |
0.189x | +11.67% |
| 2018-03-31 | Rs5.79 Billion ≈ $62.62 Million |
Rs978.13 Million ≈ $10.58 Million |
0.169x | -9.29% |
| 2017-03-31 | Rs4.90 Billion ≈ $53.00 Million |
Rs912.79 Million ≈ $9.87 Million |
0.186x | +16.66% |
| 2016-03-31 | Rs4.59 Billion ≈ $49.59 Million |
Rs731.97 Million ≈ $7.92 Million |
0.160x | -44.47% |
| 2015-03-31 | Rs2.08 Billion ≈ $22.44 Million |
Rs596.53 Million ≈ $6.45 Million |
0.287x | +57.70% |
| 2014-03-31 | Rs2.82 Billion ≈ $30.51 Million |
Rs514.22 Million ≈ $5.56 Million |
0.182x | +73.35% |
| 2013-03-31 | Rs2.96 Billion ≈ $32.01 Million |
Rs311.26 Million ≈ $3.37 Million |
0.105x | +4206.51% |
| 2012-03-31 | Rs2.19 Billion ≈ $23.73 Million |
Rs-5.62 Million ≈ $-60.78K |
-0.003x | -102.04% |
| 2011-03-31 | Rs1.76 Billion ≈ $19.08 Million |
Rs221.98 Million ≈ $2.40 Million |
0.126x | -- |
About Healthcare Global Enterprises Limited
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncol… Read more